Accedi
Accedi
Oppure accedi con
GoogleGoogle
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Apple Apple     

I Leader della Finanza

HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza 
Portrait de Gil S. Omenn
EtÓ : 81
Patrimonio pubblico : 277 062 USD
Principali societÓ : Galectin Therapeutics Inc. - Amesite Inc.
Riassunto 
Gil S. Omenn is Member-Community Preventive Services Task Force at Centers for Disease Control & Prevention, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Association of American Physicians and Vice President at Human Proteome Organization and on the board of 10 other companies.

In his past career he occupied the position of Chief Executive Officer of University of Miami Health System, Associate Director at Office of Management & Budget, Associate Director at White House Office of Science & Technology Policy, Advisor at Arboretum Ventures LLC, Chairman of tranSMART Foundation, Member-Scientific Management Review at National Institutes of Health, Associate Director at Office of Science & Technology Policy, Member of American College of Physicians, Inc., Chief Executive Officer of Michigan Medicine, President for American Association for the Advancement of Science, Executive VP-Medical Affairs & Professor at the University of Michigan, Professor at the University of Washington, Affiliate Faculty at Institute for Systems Biology, Council Member at National Academy of Medicine (United States) and Member of Fred Hutchinson Cancer Research Center.

Gil S. Omenn received a doctorate from the University of Washington, a doctorate from Harvard Medical School and an undergraduate degree from Princeton University.


Posti e reponsabilitÓ di Gil S. Omenn 
NomeTitolo Da
Galectin Therapeutics Inc.
(Biotecnologia)
Independent Director 2014
Amesite Inc.
(Software)
Independent Director 2020
Armune BioScience, Inc. Director 2008
Population Services International Director -
Salzburg Global Seminar, Inc. Director -
The CNA Corp. Trustee -
The Center for Public Integrity Director -
The Hastings Center Director -
Life Sciences Society Director -
Phenomics Health, Inc. Director -
Centers for Disease Control & Prevention Member-Community Preventive Services Task Force -
American Academy of Arts & Sciences Member -
National Academy of Medicine (United States) Member -
Association of American Physicians Member -
Human Proteome Organization Vice President 2011


Participazioni di Gil S. Omenn 
NomeAzioni%Valorizzazione
Galectin Therapeutics Inc. (GALT)
(Biotecnologia)
82 2400,13%167 770 USD
PRO PHARMACEUTICALS INC PFD SER A50 0003,57%102 000 USD
Amesite Inc. (AMST)
(Software)
3 4720,14%7 291 USD
Amesite, Inc.155 7900,96%2 USD


Gil S. Omenn: network personale 
Le notizie pi¨ lette 
29/11La Berkshire di Buffett controbatte il miliardario Haslams nella battaglia sulla valutazione di Pilot
MR
28/11Charlie Munger, l''Oracolo di Pasadena' che fu il secondo in comando di Buffett
MR
30/11Tesla consegnerà i Cybertruck dopo che Musk ha mitigato le aspettative
MR
22/11L'erede di LVMH Antoine Arnault si ritirerà dalla gestione di Berluti
MR
28/11Il vicepresidente di Berkshire Hathaway Charlie Munger muore a 99 anni
MR
22/11Factbox - I ruoli di LVMH ricoperti dai figli di Bernard Arnault
MR
26/11Il tedesco Kuehne esamina un'offerta per il grattacielo di Signa ad Amburgo - rapporto
MR
30/11La ricerca di un nuovo amministratore delegato di BP si prolungherà fino all'anno prossimo, mentre si protrae la ricerca di Looney
MR
28/11Elon Musk promette di indossare il simbolo degli ostaggi di Gaza
MR
19/11Tattarang dei Forrest australiani acquisisce l'azienda di cappelli 'iconica' Akubra
MR
Altre notizie


© 2023 People and Ownership :   
Gil S. Omenn : connessioni 


Il Mercato Azionario alla portata di tuttiRegistrazione 100% gratuita
Registrazione 100% gratuita